ARCG

——

Setup

No setup

Buy Zone

Not available

Sector

—

Industry

—

Recommendation

No setup

None

No real engine snapshot is available for this ticker yet.

ARCG chart

Loading chart…

Overall Quality

RS Rating

—

relative strength

Fundamentals

—

Not available

Volume Demand

—

vs avg unknown

Technical Setup

—

Not available

Industry/Theme

—

Computer Software-Enterprise

Trade Plan

No setup

Entry

—

Entry Zone

—

Stop / Risk

—

RS Rating

—

Volume confirmed

—

Targets

—

Strategy criteria

0 ✓ 3 ✗

Entry $195.64–$205.42Stop $179.99Target $234.77 / $244.55

Market regimeRange

Quality—

RS Rating—

How this came together

MarketRange

SetupNear pivot

ConfidenceExperimental · not backtested

Fund-Q—

StatusHold

Stock Data

52-Week Range—

Price % Chg YTD—

Price % Chg 4wk—

50-Day Avg Vol—

P/E Ratio—

Market Cap$417B

Sector—

Industry—

Company Fundamentals

EPS % Chg (Qtr)—

Sales % Chg (Qtr)—

EPS Growth 5y—

Sales Growth 5y—

Annual ROE—

Gross Margin—

Operating Margin—

Net Margin—

Debt / Equity—

Setup levels

Current price

—

Pivot

—

Distance to buy

—

52-week range

—

Trigger evidence

No active trigger evidence available.

Fundamental detail

EPS % Chg (Qtr)—

Sales % Chg (Qtr)—

EPS Growth 5y—

Sales Growth 5y—

Annual ROE—

Gross Margin—

Operating Margin—

Net Margin—

Debt / Equity—

Technical checks

Über 50-MA

Pass

Über 200-MA

Pass

RS-Linie auf neuem Hoch

Fail

Volumen bestätigt

Pass

In Kaufzone

Pass

Nicht überextended

Pass

Über 21-EMA

Pass

Volumen gesund

Fail

IBD / source mentions

WATCHLIST_ONLY2026-09-1800:21:49

Part of the ARK funds showing strength, specifically in the genomics area, which has been seeing a lot of strength.

Signal history

Added to list

2026-10-29

Trigger date

—

Days on list

Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.